Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_assertion type Assertion NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_head.
- NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_assertion description "[One patient, previously treated with mitoxantrone and cyclophosphamide for breast cancer, presented a new and, to our knowledge not previously reported, type of fusion transcript, with breakpoint at nt 399 of the CBFB gene and at nt 2134 of the MYH11 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_provenance.
- NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_assertion evidence source_evidence_literature NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_provenance.
- NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_assertion SIO_000772 9586906 NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_provenance.
- NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_assertion wasDerivedFrom befree-20150227 NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_provenance.
- NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_assertion wasGeneratedBy ECO_0000203 NP583797.RAn2kSpUY6G6nme8BYchN0jBzy0I6XDz8kK-2Q398B1h0130_provenance.